Chemoinformaics analysis of (2E)-N-methyl-3-phenyl-N-[(E)-2-phenylethenyl]prop-2-enamide
| Molecular Weight | 263.34 | nRot | 4 |
| Heavy Atom Molecular Weight | 246.204 | nRig | 15 |
| Exact Molecular Weight | 263.131 | nRing | 2 |
| Solubility: LogS | -5.144 | nHRing | 0 |
| Solubility: LogP | 3.623 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 12 |
| nHA | 1 | APOL | 43.2975 |
| nHD | 0 | BPOL | 19.6325 |
| QED | 0.768 |
| Synth | 2.255 |
| Natural Product Likeliness | 0.277 |
| NR-PPAR-gamma | 0.884 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.534 |
| Pgp-sub | 0.001 |
| HIA | 0.023 |
| CACO-2 | -4.715 |
| MDCK | 0.0000154 |
| BBB | 0.914 |
| PPB | 0.954482 |
| VDSS | 0.377 |
| FU | 0.031559 |
| CYP1A2-inh | 0.98 |
| CYP1A2-sub | 0.78 |
| CYP2c19-inh | 0.861 |
| CYP2c19-sub | 0.186 |
| CYP2c9-inh | 0.666 |
| CYP2c9-sub | 0.955 |
| CYP2d6-inh | 0.163 |
| CYP2d6-sub | 0.808 |
| CYP3a4-inh | 0.113 |
| CYP3a4-sub | 0.351 |
| CL | 3.928 |
| T12 | 0.419 |
| hERG | 0.317 |
| Ames | 0.417 |
| ROA | 0.018 |
| SkinSen | 0.873 |
| Carcinogencity | 0.739 |
| EI | 0.95 |
| Respiratory | 0.196 |
| NR-Aromatase | 0.557 |
| Antiviral | No |
| Prediction | 0.714211 |